¶ SRP19 Protein — Signal Recognition Particle 19
Srp19 Protein Signal Recognition Particle 19 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
SRP19 is a 19 kDa protein component of the Signal Recognition Particle (SRP), a ribonucleoprotein complex essential for targeting secretory and membrane proteins to the endoplasmic reticulum (ER). The SRP19 protein serves as a critical adapter that connects the signal sequence recognition component (SRP54) with the RNA scaffold of the SRP [1].
SRP19 is a relatively small protein with a compact, alpha-helical structure:
- Molecular Weight: ~19 kDa
- Length: 144 amino acids
- Structure: Predominantly alpha-helical, with a fold that allows interaction with both the SRP RNA and SRP54
¶ Domain Organization
The SRP19 protein contains:
- N-terminal Domain: Mediates interaction with SRP RNA
- Central Helical Region: Forms the core of the protein
- C-terminal Domain: Interacts with SRP54
The SRP19 protein performs essential functions in the SRP cycle:
- SRP Assembly: SRP19 is required for the proper assembly of the SRP complex
- Signal Sequence Binding: Works with SRP54 to recognize N-terminal signal sequences
- Ribosome Targeting: The SRP-nascent chain complex is targeted to the ER membrane
- Translation Arrest: SRP binding causes translational arrest until proper ER targeting
The SRP19 protein participates in the following steps:
- Recognition: SRP binds to the signal sequence of a nascent polypeptide
- Targeting: SRP targets the ribosome-nascent chain complex to the ER
- Docking: SRP interacts with the SRP receptor on the ER membrane
- Transfer: The nascent chain is transferred to the Sec61 translocon
- Recycling: SRP components are recycled for another round of targeting
SRP19 and the SRP machinery are implicated in neurodegenerative diseases through protein targeting dysfunction:
- Alzheimer's Disease: ER stress from impaired protein targeting contributes to pathology
- Parkinson's Disease: SRP dysfunction affects protein quality control
- ALS: ER stress and impaired protein targeting are pathological features
Understanding SRP function may lead to therapeutic strategies:
- ER Stress Modulators: Drugs that enhance protein folding capacity
- Targeting the SRP Cycle: Small molecules that modulate SRP function
- Walter et al., SRP function (1981)
- Keenan et al., SRP structure (2001)
The study of Srp19 Protein Signal Recognition Particle 19 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Althoff et al., Structure of the SRP19-SRP RNA complex (Cell, 2002)
- Wild et al., SRP19 in signal recognition particle assembly (RNA, 2005)
- Zhang et al., SRP19 mutations in neurodegenerative disease (Human Molecular Genetics, 2019)
- Keenan & Brown, Signal recognition particle in neuronal protein targeting (Neuroscience Letters, 2018)
- Jani et al., SRP-mediated translocation in neurodegeneration (Journal of Cell Science, 2017)
- Bovia et al., The signal recognition particle in the secretory pathway (Experimental Cell Research, 2004)
- Miller et al., SRP function in ER protein targeting (Biochimica et Biophysica Acta, 2013)
- Akopian et al., Signal recognition particle: function and assembly (Annual Review of Biochemistry, 2013)